CDC Contract Announcement

ASCT SERVICES, INC. is proud to announce that the Centers for Disease Detection and Prevention (CDC) has exercised option year one of its contract with ASCT Services to continue to conduct a Study for Cytology Workload Assessment and Measure through September 2015. Deanna Iverson, MHS, MLT (ASCP) SCTCM, HTL, a longtime employee of ASCT Services, serves as Project Leader.

The CDC’s purpose of this contract is to assess the cytology laboratory practices related to workload for cytotechnologists and to measure the actual amount of time spent by cytotechnologists in screening Pap test glass slides using an automated review microscope with both FDA-approved image-assisted slide screening systems.

“We are privileged to continue working with the CDC on this study,” said Beverly Haigler-Daly, BS, CT (ASCP), Executive Director of ASCT Services, Inc.  “It is an opportunity for all cytotechnologists to make a difference and impact the future of cytology.”

The CDC and ASCT Services, Inc. are looking for cytology laboratories that use computer-assisted screening devices (Hologic and/or Becton-Dickinson) to participate in a time measure study to be conducted between November 2014 and June 2015.  We are looking to enroll 100 cytotechnologists in this study.  This is a unique opportunity for cytotechnologists to provide data that will be used by CMS, FDA, and CDC to evaluate current workload maximums for screening using a imaging device.  Click here for more information.